23andMe Investor Presentation Deck slide image

23andMe Investor Presentation Deck

Using Human Genetics to Create Meaningful Therapeutics for Diseases with High Unmet Need in Oncology and Immunology SPEED Antibody and protein engineering Pleiotropy informs clinical development and safety NEED Creative use of pleiotropy Translational assays to address unmet medical needs Patients POWER Largest human genetics-based discovery platform 1000+ traits World's largest pleiotropy map Copyright © 2024 23and Me, Inc. 23and Me 4
View entire presentation